CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C03104 | BRD-K02206783 | BRD-K02206783 | -- | -- | -- | Details |
| C03105 | BRD-K02208014 | BRD-K02208014 | -- | -- | -- | Details |
| C03106 | BRD-K02210445 | BRD-K02210445 | -- | -- | -- | Details |
| C03107 | BRD-K02216544 | BRD-K02216544 | -- | -- | -- | Details |
| C03108 | BRD-K02217114 | BRD-K02217114 | -- | -- | -- | Details |
| C03109 | BRD-K02222982 | BRD-K02222982 | -- | -- | -- | Details |
| C03110 | BRD-K02223034 | BRD-K02223034 | -- | -- | -- | Details |
| C03111 | BRD-K02223457 | BRD-K02223457 | -- | -- | -- | Details |
| C03112 | BRD-K02227374 | milnacipran | SLC6A2; SLC6A4 | Serotonin reuptake inhibitor | -- | Details |
| C03113 | BRD-K02229102 | BRD-K02229102 | -- | -- | -- | Details |
| C03114 | BRD-K02230174 | BRD-K02230174 | -- | -- | -- | Details |
| C03115 | BRD-K02240493 | BRD-K02240493 | -- | -- | -- | Details |
| C03116 | BRD-K02240568 | BRD-K02240568 | -- | -- | -- | Details |
| C03117 | BRD-K02241254 | BRD-K02241254 | -- | -- | -- | Details |
| C03118 | BRD-K02241333 | CHIR-124 | CHEK1 | CHK inhibitor | -- | Details |
| C03119 | BRD-K02241673 | BRD-K02241673 | -- | -- | -- | Details |
| C03120 | BRD-K02242562 | BRD-K02242562 | -- | -- | -- | Details |
| C03121 | BRD-K02246294 | BRD-K02246294 | -- | -- | -- | Details |
| C03122 | BRD-K02248910 | BRD-K02248910 | -- | -- | -- | Details |
| C03123 | BRD-K02251932 | BRD-K02251932 | -- | -- | -- | Details |
| C03124 | BRD-K02256002 | BRD-K02256002 | -- | -- | -- | Details |
| C03125 | BRD-K02257023 | BRD-K02257023 | -- | -- | -- | Details |
| C03126 | BRD-K02258558 | BRD-K02258558 | -- | -- | -- | Details |
| C03127 | BRD-K02265150 | amoxapine | DRD1; DRD2; DRD3; DRD4; HTR2A; HTR6; SLC6A2; SLC6A4 | Norepinephrine reputake inhibitor | -- | Details |
| C03128 | BRD-K02269304 | BRD-K02269304 | -- | -- | -- | Details |
| C03129 | BRD-K02269790 | BRD-K02269790 | -- | -- | -- | Details |
| C03130 | BRD-K02274100 | BRD-K02274100 | -- | -- | -- | Details |
| C03131 | BRD-K02274189 | BRD-K02274189 | -- | -- | -- | Details |
| C03132 | BRD-K02275692 | cefotiam | -- | -- | -- | Details |
| C03133 | BRD-K02275742 | BRD-K02275742 | -- | -- | -- | Details |
| C03134 | BRD-K02279849 | BRD-K02279849 | -- | -- | -- | Details |
| C03135 | BRD-K02280251 | BRD-K02280251 | -- | -- | -- | Details |
| C03136 | BRD-K02283603 | BRD-K02283603 | -- | -- | -- | Details |
| C03137 | BRD-K02283807 | GR-32191 | TBXA2R | Thromboxane receptor antagonist | -- | Details |
| C03138 | BRD-K02290471 | BRD-K02290471 | -- | -- | -- | Details |
| C03139 | BRD-K02291788 | BRD-K02291788 | -- | -- | -- | Details |
| C03140 | BRD-K02292852 | cefoperazone | -- | -- | -- | Details |
| C03141 | BRD-K02299361 | BRD-K02299361 | -- | -- | -- | Details |
| C03142 | BRD-K02301426 | BRD-K02301426 | -- | -- | -- | Details |
| C03143 | BRD-K02306470 | BRD-K02306470 | -- | -- | -- | Details |
| C03144 | BRD-K02310245 | BRD-K02310245 | -- | -- | -- | Details |
| C03145 | BRD-K02311587 | BRD-K02311587 | -- | -- | -- | Details |
| C03146 | BRD-K02311826 | BRD-K02311826 | -- | -- | -- | Details |
| C03147 | BRD-K02313433 | BRD-K02313433 | -- | -- | -- | Details |
| C03148 | BRD-K02314198 | BRD-K02314198 | -- | -- | -- | Details |
| C03149 | BRD-K02314383 | epitiostanol | AR | Androgen receptor agonist | -- | Details |
| C03150 | BRD-K02315086 | BRD-K02315086 | -- | -- | -- | Details |
| C03151 | BRD-K02315366 | BRD-K02315366 | -- | -- | -- | Details |
| C03152 | BRD-K02315839 | BRD-K02315839 | -- | -- | -- | Details |
| C03153 | BRD-K02317159 | BRD-K02317159 | -- | -- | -- | Details |
| C03154 | BRD-K02321382 | BRD-K02321382 | -- | -- | -- | Details |
| C03155 | BRD-K02322717 | BRD-K02322717 | -- | -- | -- | Details |
| C03156 | BRD-K02329600 | BRD-K02329600 | -- | -- | -- | Details |
| C03157 | BRD-K02334683 | BRD-K02334683 | -- | -- | -- | Details |
| C03158 | BRD-K02337960 | BRD-K02337960 | -- | -- | -- | Details |
| C03159 | BRD-K02341205 | BRD-K02341205 | -- | -- | -- | Details |
| C03160 | BRD-K02341409 | BRD-K02341409 | -- | -- | -- | Details |
| C03161 | BRD-K02353863 | BRD-K02353863 | -- | -- | -- | Details |
| C03162 | BRD-K02354331 | BRD-K02354331 | -- | -- | -- | Details |
| C03163 | BRD-K02356765 | BRD-K02356765 | -- | -- | -- | Details |
| C03164 | BRD-K02361314 | BRD-K02361314 | -- | -- | -- | Details |
| C03165 | BRD-K02362691 | BRD-K02362691 | -- | -- | -- | Details |
| C03166 | BRD-K02371763 | BRD-K02371763 | -- | -- | -- | Details |
| C03167 | BRD-K02372107 | BRD-K02372107 | -- | -- | -- | Details |
| C03168 | BRD-K02374169 | BRD-K02374169 | -- | -- | -- | Details |
| C03169 | BRD-K02375958 | BRD-K02375958 | -- | -- | -- | Details |
| C03170 | BRD-K02381115 | BRD-K02381115 | -- | -- | -- | Details |
| C03171 | BRD-K02388444 | BRD-K02388444 | -- | -- | -- | Details |
| C03172 | BRD-K02389548 | RG-2833 | -- | -- | -- | Details |
| C03173 | BRD-K02392990 | BRD-K02392990 | -- | -- | -- | Details |
| C03174 | BRD-K02393180 | BRD-K02393180 | -- | -- | -- | Details |
| C03175 | BRD-K02395808 | BRD-K02395808 | -- | -- | -- | Details |
| C03176 | BRD-K02401733 | BRD-K02401733 | -- | -- | -- | Details |
| C03177 | BRD-K02403042 | BRD-K02403042 | -- | -- | -- | Details |
| C03178 | BRD-K02404261 | caffeine | ADORA1; ADORA2A; ADORA2B; ITPR1; ATM; RYR1 | Phosphodiesterase inhibitor; Adenosine receptor antagonist | -- | Details |
| C03179 | BRD-K02407574 | parbendazole | TUBB | Tubulin inhibitor | -- | Details |
| C03180 | BRD-K02409808 | BRD-K02409808 | -- | -- | -- | Details |
| C03181 | BRD-K02410399 | aminobenztropine | -- | -- | -- | Details |
| C03182 | BRD-K02418197 | BRD-K02418197 | -- | -- | -- | Details |
| C03183 | BRD-K02419152 | BRD-K02419152 | -- | -- | -- | Details |
| C03184 | BRD-K02420839 | BRD-K02420839 | -- | -- | -- | Details |
| C03185 | BRD-K02420864 | BRD-K02420864 | -- | -- | -- | Details |
| C03186 | BRD-K02421873 | EMF-sumo1-12 | -- | -- | -- | Details |
| C03187 | BRD-K02427049 | BRD-K02427049 | -- | -- | -- | Details |
| C03188 | BRD-K02437976 | BRD-K02437976 | -- | -- | -- | Details |
| C03189 | BRD-K02442093 | BRD-K02442093 | -- | -- | -- | Details |
| C03190 | BRD-K02442533 | 2-CHLOROACETOPHENONE | -- | -- | -- | Details |
| C03191 | BRD-K02445308 | BRD-K02445308 | -- | -- | -- | Details |
| C03192 | BRD-K02445831 | BRD-K02445831 | -- | -- | -- | Details |
| C03193 | BRD-K02446652 | BRD-K02446652 | -- | -- | -- | Details |
| C03194 | BRD-K02448874 | BRD-K02448874 | -- | -- | -- | Details |
| C03195 | BRD-K02458594 | KU-C103869 | -- | -- | -- | Details |
| C03196 | BRD-K02460212 | BRD-K02460212 | -- | -- | -- | Details |
| C03197 | BRD-K02471501 | BRD-K02471501 | -- | -- | -- | Details |
| C03198 | BRD-K02473319 | BRD-K02473319 | -- | -- | -- | Details |
| C03199 | BRD-K02475229 | BRD-K02475229 | -- | -- | -- | Details |
| C03200 | BRD-K02484256 | BRD-K02484256 | -- | -- | -- | Details |
| C03201 | BRD-K02485640 | BRD-K02485640 | -- | -- | -- | Details |
| C03202 | BRD-K02490038 | BQ-788 | -- | -- | -- | Details |
| C03203 | BRD-K02490064 | BRD-K02490064 | -- | -- | -- | Details |